Ocugen (OCGN) Amortization of Deferred Charges (2014 - 2026)
Ocugen (OCGN) posted Amortization of Deferred Charges of $25000.0 for Q1 2026, little changed on a QoQ basis from $25000.0 in Q4 2025, and down 91.67% year-over-year from $300000.0 in Q1 2025.
Ocugen (OCGN) Amortization of Deferred Charges (2014 - 2026) Analysis & Trends
Ocugen's Amortization of Deferred Charges history runs 10 years deep, the most recent figure standing at $25000.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges fell 91.67% year-over-year to $25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$175000.0 (down 160.98% YoY) and the FY2025 annual result came in at $100000.0, up 525.0% from the prior year.
- Amortization of Deferred Charges was $25000.0 for Q1 2026 at Ocugen, roughly flat from $25000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $300000.0 in Q1 2025 and bottomed at -$250000.0 in Q2 2025.
- A 5-year average of $20000.0 and a median of $25000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Peak annual rise in Amortization of Deferred Charges reached 934.48% in 2025, while the deepest fall reached 992.86% in 2025.
- Ocugen's Amortization of Deferred Charges stood at $25000.0 in 2022, then climbed by 16.0% to $29000.0 in 2023, then slumped by 344.83% to -$71000.0 in 2024, then soared by 135.21% to $25000.0 in 2025, then changed by 0.0% to $25000.0 in 2026.
- Business Quant data shows OCGN's Amortization of Deferred Charges at $25000.0 in Q1 2026, $25000.0 in Q4 2025, and $25000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ocugen | 415.98 Mn | 415.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | -250,000.00 |
| Jun 30, 2025 | -250,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | -71,000.00 |
| Dec 31, 2024 | -71,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |